文献速递妇科

宫颈癌和子宫内膜癌初次手术治疗中机器人辅助盆腔淋巴结切除术后症状性淋巴囊肿:回顾性队列研究

Symptomatic Lymphocele After Robot-Assisted Pelvic Lymphadenectomy as Part of the Primary Surgical Treatment for Cervical and Endometrial Cancer: A Retrospective Cohort Study.
PubMed 文献 · J Minim Invasive Gynecol · 2024-01-01

该回顾性队列研究纳入2008至2022年间387例接受机器人辅助腹腔镜盆腔淋巴结切除的早期宫颈癌(258例)和高/中高危子宫内膜癌(129例)患者,症状性淋巴囊肿总体发生率为9.6%,中位随访47个月;吸烟是全队列唯一显著危险因素(多因素OR 2.42,95%CI 1.16-5.07)。

要点

  • 症状性淋巴囊肿总体发生率为9.6%,中位随访47个月。
  • 吸烟是全队列唯一显著危险因素(多因素OR 2.42,95%CI 1.16-5.07)。
  • 宫颈癌中BMI和既往腹部手术为独立危险因素;子宫内膜癌中年龄为独立危险因素。

核心结论

  • 该单中心队列研究显示,宫颈癌和子宫内膜癌机器人辅助腹腔镜盆腔淋巴结切除术后症状性淋巴囊肿发生率接近10%,诊断时吸烟者风险更高。
  • 两种人群的危险因素不同,作者认为需进一步研究以建立风险模型。

研究设计与样本

  • 回顾性队列研究,单中心学术医院,纳入2008至2022年间接受机器人辅助腹腔镜盆腔淋巴结切除的早期宫颈癌及高/中高危子宫内膜癌患者,共387例(宫颈癌258例,子宫内膜癌129例)。

主要发现

  • 症状性淋巴囊肿总体发生率为9.6%,中位随访47个月(四分位距23-61)。
  • 全队列单因素分析中吸烟OR 2.47(95%CI 1.19-5.11),多因素分析中吸烟OR 2.42(95%CI 1.16-5.07)。
  • 宫颈癌中BMI(OR 1.09,95%CI 1.00-1.17)和既往腹部手术(OR 2.75,95%CI 1.22-6.17)为显著独立危险因素。
  • 子宫内膜癌中年龄为显著独立危险因素(OR 0.90,95%CI 0.83-0.97)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY OBJECTIVES: Pelvic lymph node dissection (PLND) is part of the primary treatment for early-stage cervical cancer and high-intermediate risk or high-risk endometrial cancer. Pelvic lymphocele is a postoperative complication of PLND, and when symptomatic, lymphoceles necessitate treatment. The aim of this study was to investigate the incidence and risk factors of symptomatic lymphocele after robot-assisted laparoscopic PLND in cervical and endometrial cancer. DESIGN: Retrospective cohort study. SETTING: Single-center academic hospital. PATIENTS: Two hundred and fifty-eight patients with cervical cancer and 129 patients with endometrial cancer. INTERVENTIONS: Pelvic lymphadenectomy by robot-assisted laparoscopic surgery. MEASUREMENTS AND MAIN RESULTS: The authors retrospectively included all patients with early-stage cervical cancer and high-intermediate risk or high-risk endometrial cancer who underwent pelvic lymphadenectomy by robot-assisted laparoscopic surgery between 2008 and 2022. Medical records were reviewed for the occurrence of a symptomatic lymphocele. Univariate and multivariate logistic regression analyses were conducted to identify risk factors for developing a symptomatic lymphocele. In total, 387 patients, 258 with cervical cancer and 129 with endometrial cancer, were included in the study. The overall incidence of symptomatic lymphoceles was 9.6% with a median follow-up of 47 months [interquartile range 23-61]. For the entire cohort, smoking was the only significant risk factor for symptomatic lymphoceles identified in univariate (OR 2.47, 95% CI 1.19-5.11) and multivariate analysis (OR 2.42, 95% CI 1.16-5.07). For cervical cancer, body mass index (BMI) (OR 1.09, 95% CI 1.00-1.17) and prior abdominal surgery (OR 2.75, 95% CI 1.22-6.17) were also identified as significant independent risk factors. For endometrial cancer, age was identified as a significant independent risk factor (OR 0.90, 95% CI 0.83-0.97). CONCLUSION: This single-center cohort study demonstrated an incidence of almost 10% of symptomatic lymphoceles after robot-assisted laparoscopic PLND for cervical cancer and endometrial cancer, with a higher risk observed among patients who smoke at the time of diagnosis. Furthermore, risk factors differ between the 2 populations, necessitating further studies to establish risk models.

来源:J Minim Invasive Gynecol,查看原文。版权归原作者所有。

引用

  1. de Jong A, Baeten IGT, Jansen A, et al. Symptomatic Lymphocele After Robot-Assisted Pelvic Lymphadenectomy as Part of the Primary Surgical Treatment for Cervical and Endometrial Cancer: A Retrospective Cohort Study. J Minim Invasive Gynecol. 2024. PMID: 38171478. doi:10.1016/j.jmig.2023.12.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。